ValiRx (VAL) Competitors GBX 0.71 -0.04 (-5.87%) As of 12:05 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock VAL vs. MXC, EOG, HNR, SUN, NOG, WRES, EQT, CRC, WEB, and NBLShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Argent BioPharma (MXC), Europa Oil & Gas (EOG), Highlands Natural Resources (HNR), Surgical Innovations Group (SUN), Nostrum Oil & Gas (NOG), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), and 18564 (NBL.L) (NBL). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Its Competitors Argent BioPharma Europa Oil & Gas Highlands Natural Resources Surgical Innovations Group Nostrum Oil & Gas W Resources EQTEC Circle Property Webis 18564 (NBL.L) ValiRx (LON:VAL) and Argent BioPharma (LON:MXC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends. Is VAL or MXC more profitable? Argent BioPharma has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Argent BioPharma's return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets ValiRx-20,554.01% -55.84% -35.98% Argent BioPharma N/A N/A -58.96% Do institutionals & insiders believe in VAL or MXC? 35.4% of ValiRx shares are held by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are held by institutional investors. 54.1% of ValiRx shares are held by company insiders. Comparatively, 8.2% of Argent BioPharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, VAL or MXC? ValiRx has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Argent BioPharma has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Does the media favor VAL or MXC? In the previous week, ValiRx's average media sentiment score of 0.00 equaled Argent BioPharma'saverage media sentiment score. Company Overall Sentiment ValiRx Neutral Argent BioPharma Neutral Which has higher valuation & earnings, VAL or MXC? ValiRx has higher earnings, but lower revenue than Argent BioPharma. ValiRx is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValiRx£49.78K53.10-£5.71M-£0.01-48.69Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A SummaryValiRx and Argent BioPharma tied by winning 5 of the 10 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.64M£236.97M£5.86B£2.58BDividend Yield0.63%3.78%5.68%5.30%P/E Ratio-48.6940.7756.455,410.66Price / Sales53.104,994.05536.0096,691.07Price / Cash62.5013.1937.5627.93Price / Book0.26103.7512.167.76Net Income-£5.71M-£90.99M£3.28B£5.89B7 Day Performance-2.62%3.36%0.98%6.49%1 Month Performance32.21%23.87%7.20%56.20%1 Year Performance-66.38%550.36%63.06%148.15% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.71-5.9%N/A-63.5%£2.64M£49.78K-48.695,450Gap DownMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpEOGEuropa Oil & GasN/AGBX 0.82-4.1%N/A-18.8%£7.82M£3.57M-114.792,850News CoverageGap UpHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.73+4.7%N/A+12.5%£6.84M£11.95M-349.0580Gap UpNOGNostrum Oil & Gas1.493 of 5 starsGBX 3.98+13.4%GBX 4+0.5%-0.5%£6.57M£135.89M-2.9530Gap UpWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.45+12.5%N/A-51.5%£2.75M£2.20M-6.62740Gap UpCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330 Related Companies and Tools Related Companies Argent BioPharma Alternatives Europa Oil & Gas Alternatives Highlands Natural Resources Alternatives Surgical Innovations Group Alternatives Nostrum Oil & Gas Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VAL Stock Alerts